Wordt geladen...
Physostigmine for dementia due to Alzheimer's disease
BACKGROUND: The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after it has been secreted into t...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2001
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8078195/ https://ncbi.nlm.nih.gov/pubmed/11405996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001499 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|